Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,349Revenue $M7,146Net Margin (%)7.0Z-Score3.0
Enterprise Value $M14,071EPS $5.5Operating Margin %13.6F-Score6
P/E(ttm))20.7Cash Flow Per Share $5.2Pre-tax Margin (%)11.8Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %8.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %6.8Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %-20.8ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)12.7Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M145ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 71.3216%Add 5330.13%238,057
DGXScott Black 2014-09-30 Sold Out $59.28 - $64.08
($61.73)
$ 71.3216%Sold Out0
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 71.3216%Reduce -36.86%1,593,262
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 71.3222%Add 4465.97%4,672,681
DGXScott Black 2014-06-30 Buy $55.5 - $61.75
($58.56)
$ 71.3222%New holding, 220 sh.220
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 71.3222%Reduce -55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 71.3222%Reduce -18%82,000
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 71.3222%Reduce -26.19%35,982
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 71.3222%Reduce -94.26%4,384
DGXRay Dalio 2014-06-30 Reduce-0.03%$55.5 - $61.75
($58.56)
$ 71.3222%Reduce -82.85%13,545
DGXHOTCHKIS & WILEY 2014-03-31 Add0.1%$50.8 - $57.99
($53.53)
$ 71.3233%Add 23.69%2,495,500
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 71.3233%Add 66.84%48,748
DGXRay Dalio 2014-03-31 Buy 0.04%$50.8 - $57.99
($53.53)
$ 71.3233%New holding, 78977 sh.78,977
DGXChris Davis 2014-03-31 Buy 0.02%$50.8 - $57.99
($53.53)
$ 71.3233%New holding, 102337 sh.102,337
DGXJoel Greenblatt 2014-03-31 Reduce-0.26%$50.8 - $57.99
($53.53)
$ 71.3233%Reduce -72.63%76,412
DGXJoel Greenblatt 2013-12-31 Add0.3%$52.79 - $63.7
($59.36)
$ 71.3220%Add 533.63%279,188
DGXRichard Pzena 2013-12-31 Add0.17%$52.79 - $63.7
($59.36)
$ 71.3220%Add 81.17%1,215,050
DGXJohn Rogers 2013-12-31 Add0.15%$52.79 - $63.7
($59.36)
$ 71.3220%Add 447.73%268,053
DGXBrian Rogers 2013-12-31 Add0.11%$52.79 - $63.7
($59.36)
$ 71.3220%Add 25%2,750,000
DGXDavid Dreman 2013-12-31 Reduce-0.06%$52.79 - $63.7
($59.36)
$ 71.3220%Reduce -28.19%29,218
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DGX Brian Rogers 2014-12-313,000,0002.080.72
DGX Joel Greenblatt 2014-09-30238,0570.160.14+5330.13%
DGX Ray Dalio 2014-09-3015,6260.010.01+15.36%
DGX Chris Davis 2014-09-304,879,4163.380.92+4.42%
DGX Robert Olstein 2014-09-3082,0000.060.65
DGX Richard Pzena 2014-09-30429,7000.30.14-0.32%
DGX John Rogers 2014-09-30348,9100.240.27-1.14%
DGX David Dreman 2014-09-3033,8980.020.17-5.79%
DGX HOTCHKIS & WILEY 2014-09-301,593,2621.10.35-36.86%
DGX Scott Black 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$6411.44view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.1312.97view
PFEIFFER GARY MDirector 2014-11-10Sell10,000$61.6915.61view
Doherty Catherine T.SVP, Physician Services Bus. 2014-11-03Sell23,667$62.1914.68view
Doherty Catherine T.SVP, Clinical Franchises 2014-08-08Sell25,000$60.1218.63view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-08-04Sell14,377$61.0116.9view
PREVOZNIK MICHAEL ESVP & General Counsel 2014-07-30Sell16,384$62.5114.09view
BRITELL JENNE KDirector 2014-07-30Sell8,000$62.3714.35view
BALDWIN JOHN C MDDirector 2014-07-29Sell8,000$62.3114.46view
BONGIORNO THOMAS FVP and Corporate Controller 2014-07-28Sell4,000$61.7215.55view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 05 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Apr 29 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Apr 28 2014 


    More From Other Websites
    Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and... Jan 28 2015
    Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and... Jan 28 2015
    Will Quest Diagnostics' (DGX) Earnings Surprise in Q4? - Analyst Blog Jan 27 2015
    Quest Diagnostics To Release Fourth Quarter And Full Year 2014 Financial Results On January 29 Jan 13 2015
    Quest Diagnostics To Release Fourth Quarter And Full Year 2014 Financial Results On January 29 Jan 13 2015
    Quest Diagnostics Names New Health Plan Leader Jan 08 2015
    Quest Diagnostics To Speak At The 33rd Annual J.P. Morgan Healthcare Conference Jan 06 2015
    Monday's Market Recap Jan 05 2015
    Quest Diagnostics to Speak at the Goldman Sachs Healthcare CEOs Unscripted Conference Jan 05 2015
    Quest Diagnostics to Speak at the Goldman Sachs Healthcare CEOs Unscripted Conference Jan 05 2015
    LabCorp, Quest Rise on Upgrades Jan 02 2015
    Quest, LabCorp among S&P 500's top gainers after upgrades Jan 02 2015
    Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again Dec 12 2014
    FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include Eight Circulating... Dec 09 2014
    FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include Eight Circulating... Dec 09 2014
    What's behind Quest put buying Dec 05 2014
    Quest Diagnostics Declares Quarterly Cash Dividend Dec 04 2014
    Quest Diagnostics Declares Quarterly Cash Dividend Dec 04 2014
    Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference Dec 01 2014
    Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference Dec 01 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK